2-aryloxazolines inhibit Candida clinical isolates growth and morphogenesis of Candida albicans and Candida tropicalis
New antifungal molecules are being researched addressing new targets and mechanisms of action. Therefore, the present study aimed to evaluate the antifungal activity of 2-aryloxazoline derivatives (4i and 9i) on Candida clinical isolates and on morphogenesis of competent-filament species. Both compo...
שמור ב:
| Principais autores: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2024-06-01
|
| סדרה: | The Microbe |
| נושאים: | |
| גישה מקוונת: | http://www.sciencedirect.com/science/article/pii/S2950194624000293 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|